Page 31 - Chumakov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chumakov center submits its COVID-19 vaccine dossier for WHO prequalification According to the Center’s director Aidar Ishmukhametov, prequalification is a long process, it is too early to talk about timing MOSCOW, April 28. /TASS/. The Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences has submitted a vaccine dossier to the World Health Organization (WHO) for prequalification of its CoviVac vaccine, the Center’s director, Aidar Ishmukhametov, said in a televised interview with Rossiya-24 channel on Wedne...

Some 12.1 mln have received their first vaccine dose, Deputy Prime Minister Tatyana Golikova said MOSCOW, April 27. /TASS/. More than 12 mln Russians have received at least one dose of a coronavirus vaccine, and 7.7 mln have been fully vaccinated, Deputy Prime Minister Tatyana Golikova said at a meeting of the Council of Legislators of the Russian Federation on Tuesday. "As many as 12.1 mln of our fellow citizens have received their first vaccine dose and 7.7 mln have been fully vaccinated," she revealed. Read also Golikova specified that 28 mln double vaccine doses had been produced in Russi...

MOSCOW, April 27. /TASS/. Russia’s Chumakov Center can manufacture up to one million sets of its CoviVac coronavirus vaccine doses in three months, Aidar Ishmukhametov, director general of the center and a corresponding member of the Russian Academy of Sciences, told TASS on Tuesday. "Our center has a well-oiled production of vaccines. In the first quarter of this year, we manufactured as many vaccines as we had planned. We can make up to one million CoviVac vaccine sets quarterly," he said. Deputy Chairman of the Russian Security Council Dmitry Medvedev said on Monday that the production p...

On March 25, the Chumakov Center launched production of the third Russian COVID-19 vaccine dubbed CoviVac

By today, three anti-coronavirus vaccines have been registered in Russia © Peter Kovalev/TASS MOSCOW, April 20. /TASS/. /TASS/. It will be possible to vaccinate 70% of Russia’s population against the coronavirus infection by November 2021, Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry, the Sputnik V vaccine developer, said on Tuesday. "If the entire global immune-biological industry is mobilized to manufacture any particular vaccine, say, Sputnik V, all production facilities in the United States, Eu...